New Vice-chair Appointed to Commission on Human Medicines
News Jan 27, 2015
The CHM advises on matters relating to safety, quality and the efficacy of medicines as well as the collection of adverse drug reactions.
Dr Angela Thomas is a consultant paediatric haematologist at the Royal Hospital for Sick Children in Edinburgh, a fellow of the Royal College of Physicians in Edinburgh, a former President of the British Society for Haematology and has been on the CHM since 2005, where she chairs the Clinical Trials, Biologicals & Vaccines Expert Advisory Group.
She has also served as a member and chaired many scientific and medical committees in the UK and Europe.
Dr Angela Thomas said: “I am delighted to be taking up this new role. The Commission plays a vital role in the licensing of new medicines and in monitoring drug safety. I have found my time as a member of CHM tremendously rewarding and am looking forward to the challenges offered in my new role as vice-chair.”
Methane Hydrate Formation Studied Using Novel MicroreactorNews
Researchers at the NYU Tandon School of Engineering are using a novel means of studying how methane and water form methane hydrate that allows them to examine discrete steps in the process faster and more efficiently.READ MORE
University of Huddersfield Honorary Award Goes to RSC’s First Woman PresidentNews
The first woman President of the Royal Society of Chemistry, Professor Lesley Yellowlees, will collect an honorary award from University of Huddersfield, which will be presented at the University’s November Award Ceremonies.READ MORE
Drug Discovery Alliance Formed to Help Increase Drug Development Success RateNews
Two prominent preclinical safety companies have launched a unique European alliance to address the high safety-related failure rate in drug development.READ MORE